Neuland Labs to focus on contract research
Hyderabad-based mid-sized pharma player Neuland Labs has raised $30 million for capital expenditure on contract research facilities and its foray into clinical research.
By J Padmapriya, TNN |
BANGALORE: Hyderabad-based mid-sized pharma player Neuland Labs has raised $30 million for capital expenditure on contract research facilities and its foray into clinical research.
The Rs 202-crore bulk drug player is eyeing opportunities in contract research and manufacturing and, as a strategy, has skipped generics play. Most pharma players in the API and bulk drugs space typically move on to generics and formulation segments.
Talking to ET, Neuland chairman and managing director D R Rao says, ���We are not looking at generics business for now. This positioning gives us an advantage with clients looking for contract research and manufacturing as we will not be competing with them.���
The company is expecting that bulk of its revenues, going forward, would come from contract research and manufacturing. It has set up a chemistry-based contract research facility at an investment of Rs 60 crore complete with 80 scientists, 18 of whom are PhDs.
The Rs 202-crore bulk drug player is eyeing opportunities in contract research and manufacturing and, as a strategy, has skipped generics play. Most pharma players in the API and bulk drugs space typically move on to generics and formulation segments.
Talking to ET, Neuland chairman and managing director D R Rao says, ���We are not looking at generics business for now. This positioning gives us an advantage with clients looking for contract research and manufacturing as we will not be competing with them.���
The company is expecting that bulk of its revenues, going forward, would come from contract research and manufacturing. It has set up a chemistry-based contract research facility at an investment of Rs 60 crore complete with 80 scientists, 18 of whom are PhDs.
Start a SIP with as low as ₹500 with ET Money App!
Download
The Economic Times News App for Quarterly Results, Latest News in ITR, Business, Share Market, Live Sensex News & More.
The Economic Times News App for Quarterly Results, Latest News in ITR, Business, Share Market, Live Sensex News & More.
ADVERTISEMENT
